Amgen

AMG 305

Biodrugs/ Drugs
Cancer
Phase 1 First-In-Human Study to Explore the Safety, Tolerability, and Pharmacokinetics of AMG 305 in Subjects With Advanced Solid Tumors
1Phase I in Spain